Login to Your Account

Gilead Shares Drop on Earnings Impacted by Health Care Reforms

By Catherine Hollingsworh

Thursday, April 22, 2010
Despite increased total revenues and product sales in the first quarter, Gilead Sciences Inc. saw its shares sink 9.6 percent Wednesday as the company reported that health care reform provisions negatively affected its HIV franchise. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription